AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (16.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access | Just Accepted

Stimuli-responsive peptide-based nanomaterials for overcoming tumor therapy resistance

Suyongde Zheng1, Xiang-Peng Li1, Lumin Sun3,4, Jingyu Shen6, Hui-Hui You1, Yaofei Zhao1, Xiao Liu1, Wenbo Wang5( ), Rongchen Xu2( ), Da-Yong Hou1( ), Xiu-Hai Wu1( )

1 Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin 150001, China

2 Department of Stomatology, The First Medical Center, Chinese PLA General Hospital, Beijing, China

3 Department of Orthodontics, Heilongjiang Tuanyuan Dental Hospital, Harbin 150001, China

4 Department of Orthodontics, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China

5 Shaanxi Key Laboratory of Biomaterials and Synthetic Biology, School of Chemical Engineering, Northwest University, Xi’an 710127, China

6 Department of Health Management, Aerospace Center Hospital, Beijing 100049, China

Show Author Information

Abstract

Cancer remains the leading cause of death worldwide and tumor drug resistance markedly diminishes the effectiveness of many treatments. Resistance arises not only from intrinsic factors within cancer cells but also from extrinsic mechanisms within the tumor microenvironment (TME). To address this challenge, researchers have combined stimuli-responsive peptides with nanomaterials capable of responding to endogenous or exogenous signals, thereby overcoming resistance through multiple synergistic mechanisms. This review emphasizes how rational peptide design enhances signal responsiveness and therapeutic accuracy, systematically summarizes recent advances in breaking through tumor drug resistance, and elaborates the advantages and limitations of endogenous and exogenous responsive nanomaterials. Finally, we discuss current challenges and future directions toward promoting clinical translation.

Graphical Abstract

References

【1】
【1】
 
 
Nano Research

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zheng S, Li X-P, Sun L, et al. Stimuli-responsive peptide-based nanomaterials for overcoming tumor therapy resistance. Nano Research, 2026, https://doi.org/10.26599/NR.2026.94909326
Topics:

32

Views

3

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 09 October 2026
Revised: 09 November 2026
Accepted: 10 November 2026
Available online: 10 November 2026

© The Author(s) 2026. Published by Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/)